Pratt JA - Search Results

1

The schizophrenia risk gene Map2k7 regulates responding in a novel contingency-shifting rodent touchscreen gambling task.

Openshaw RL, Pratt JA, Morris BJ. Openshaw RL, et al. Among authors: pratt ja. Dis Model Mech. 2022 Mar 1;15(3):dmm049310. doi: 10.1242/dmm.049310. Epub 2022 Mar 11. Dis Model Mech. 2022. PMID: 35275161 Free PMC article.

2

Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol.

Cochran SM, McKerchar CE, Morris BJ, Pratt JA. Cochran SM, et al. Among authors: pratt ja. Neuropharmacology. 2002 Sep;43(3):394-407. doi: 10.1016/s0028-3908(02)00091-6. Neuropharmacology. 2002. PMID: 12243769

3

Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain.

Cochran SM, Fujimura M, Morris BJ, Pratt JA. Cochran SM, et al. Among authors: pratt ja. Synapse. 2002 Dec 1;46(3):206-14. doi: 10.1002/syn.10126. Synapse. 2002. PMID: 12325047

4

Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.

Cochran SM, Kennedy M, McKerchar CE, Steward LJ, Pratt JA, Morris BJ. Cochran SM, et al. Among authors: pratt ja. Neuropsychopharmacology. 2003 Feb;28(2):265-75. doi: 10.1038/sj.npp.1300031. Neuropsychopharmacology. 2003. PMID: 12589379

5

The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors.

Steward LJ, Kennedy MD, Morris BJ, Pratt JA. Steward LJ, et al. Among authors: pratt ja. Neuropharmacology. 2004 Sep;47(4):527-37. doi: 10.1016/j.neuropharm.2004.04.020. Neuropharmacology. 2004. PMID: 15380371

6

Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain.

Reynolds LM, Cochran SM, Morris BJ, Pratt JA, Reynolds GP. Reynolds LM, et al. Among authors: pratt ja. Schizophr Res. 2005 Mar 1;73(2-3):147-52. doi: 10.1016/j.schres.2004.02.003. Schizophr Res. 2005. PMID: 15653257

7

PCP: from pharmacology to modelling schizophrenia.

Morris BJ, Cochran SM, Pratt JA. Morris BJ, et al. Among authors: pratt ja. Curr Opin Pharmacol. 2005 Feb;5(1):101-6. doi: 10.1016/j.coph.2004.08.008. Curr Opin Pharmacol. 2005. PMID: 15661633 Review.

8

Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia.

Egerton A, Reid L, McKerchar CE, Morris BJ, Pratt JA. Egerton A, et al. Among authors: pratt ja. Psychopharmacology (Berl). 2005 Apr;179(1):77-84. doi: 10.1007/s00213-004-2109-y. Epub 2005 Jan 29. Psychopharmacology (Berl). 2005. PMID: 15682304

9

Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs.

Paterson GJ, Ohashi Y, Reynolds GP, Pratt JA, Morris BJ. Paterson GJ, et al. Among authors: pratt ja. J Psychopharmacol. 2006 Sep;20(5):636-42. doi: 10.1177/0269881106062025. Epub 2006 Feb 14. J Psychopharmacol. 2006. PMID: 16478754

10

M4 agonists/5HT7 antagonists with potential as antischizophrenic drugs: serominic compounds.

Suckling CJ, Murphy JA, Khalaf AI, Zhou SZ, Lizos DE, van Nhien AN, Yasumatsu H, McVie A, Young LC, McCraw C, Waterman PG, Morris BJ, Pratt JA, Harvey AL. Suckling CJ, et al. Among authors: pratt ja. Bioorg Med Chem Lett. 2007 May 1;17(9):2649-55. doi: 10.1016/j.bmcl.2007.01.093. Epub 2007 Feb 2. Bioorg Med Chem Lett. 2007. PMID: 17317171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page